News
January 16, 2025
FRONTEO’s Drug Discovery AI Factory, an AI drug discovery service using unique technologies that discover unreported relationships from published literature, to support target identification and drug repositioning etc.
May 13, 2024
FRONTEO, Inc. (Head Office: Tokyo, Japan; Chief Executive Officer: Masahiro Morimoto; hereafter "FRONTEO"), Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi; hereafter "Shionogi"), and Suzuken Co., Ltd. (Head Office: Nagoya, Japan; President and CEO: Shigeru Asano; hereafter "Suzuken") are pleased to announce that we will collaborate with the aim of implementing the conversational dementia diagnosis support AI program in society.
December 6, 2022
NEW YORK, December 6, 2022 – FRONTEO (TSE: 2158) has announced it has developed a new core algorithm for its AI review tool, "KIBIT Automator".
February 6, 2024
Enhanced function of the Drug Discovery AI Factory, analyze cutting-edge academic articles to propose highly novel target molecules and hypotheses
January 30, 2024
We have enhanced our existing forensic services with new cutting-edge digital forensics software package, and we are working on adding more certified forensic experts to our staff.
March 15, 2023
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
January 20, 2023
Earlier in 2022, FRONTEO was pleased to announce the release of its proprietary e-Discovery hosting platform called KIBIT Automator Review or KAMR.
March 14, 2019
January 24, 2024
Explanation of points to keep in mind when Japanese companies negotiate with U.S. government agencies, crisis management, and the use of AI
September 26, 2023
NEW YORK, September 25, 2023 – FRONTEO (TSE: 2158) announces that it has received a patent application notice from the Japan Patent Office for a new technology that uses its proprietary AI engine "KIBIT" to analyze hashed¹⁾ confidential information that cannot be decrypted.
February 15, 2017
September 9, 2022
U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
October 5, 2023
NEW YORK, October 5, 2023 – FRONTEO (TSE: 2158) is pleased to announce that Shiho Tanaka, Global Sales Executive, LegalTech AI Division, FRONTEO, Inc and Senior Vice President, Data Science & Technology Department, FRONTEO USA, will be speaking at the 5th White Collar Crime Workshop 2023, organized by Daisuke Fukamizu of Nagashima Ohno & Tsunematsu, LLP.
April 17, 2020
January 30, 2017
January 8, 2019
November 14, 2024
Accelerate indication identification and early licensing with FRONTEO’s unique technologies that systematically discovers unreported relationships between diseases and molecules from existing literature information.
June 27, 2023
NEW YORK, June 27, 2023 – FRONTEO (TSE: 2158) is pleased to announce it has developed a new technology that analyzes hashed data (patent pending) with its in-house developed AI engine "KIBIT".